Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
We identify safer crypto choices for newcomers, covering safety features, liquidity signals, and a starter framework.
18,936 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Treasury Secretary Scott Bessent pitched a bold growth plan: 3% GDP growth without higher inflation, anchored by AI-d...
SkyWater Technology just posted a record revenue figure, but the CFO sold about $2.5 million worth of stock. This art...
Midweek market news can move fast. This Wednesday reads guide curates clear, actionable investing ideas—from AI hype ...
BNB rose on March 24, 2026, as volume surged and traders weigh whether it can reach the monthly target, boosted by st...
A social-media frenzy around trillionaire wealth centers on Elon Musk, sparking a debate about how market values, pri...
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
A bold revenue target from Micron points to a surprisingly durable AI demand wave. This piece breaks down what the gu...
Biotech stocks can swing on earnings surprises. This article explains why lenz therapeutics stock crashed, what it me...
Alpha Omega Semiconductor stock has doubled this year, but is the rally justified? This guide breaks down the busines...
Circle Internet Group stock took a sharp drop as headlines pointed to potential US regulation that could curb stablec...
The Federal Reserve’s 2026 annual stress test finds the largest U.S. banks would weather a sharp downturn without fai...